US 11,697,673 B2
Camp receptor protein variant and method of producing L-amino acid using the same
Seok Myung Lee, Seoul (KR); Ki Yong Cheong, Seoul (KR); Chang Il Seo, Seoul (KR); and Ji Sun Lee, Seoul (KR)
Assigned to CJ CHEILJEDANG CORPORATION, Seoul (KR)
Appl. No. 16/956,799
Filed by CJ CHEILJEDANG CORPORATION, Seoul (KR)
PCT Filed Jul. 25, 2019, PCT No. PCT/KR2019/009292
§ 371(c)(1), (2) Date Jun. 22, 2020,
PCT Pub. No. WO2020/111437, PCT Pub. Date Jun. 4, 2020.
Claims priority of application No. 10-2018-0151043 (KR), filed on Nov. 29, 2018.
Prior Publication US 2021/0363197 A1, Nov. 25, 2021
Int. Cl. C07K 14/245 (2006.01); C12N 15/70 (2006.01); C12P 13/08 (2006.01); C12P 13/22 (2006.01); C12N 1/20 (2006.01); C12R 1/19 (2006.01)
CPC C07K 14/245 (2013.01) [C12N 1/205 (2021.05); C12P 13/08 (2013.01); C12P 13/22 (2013.01); C12R 2001/19 (2021.05)] 10 Claims
 
1. A cAMP receptor protein variant, wherein the cAMP receptor protein variant has transcription regulator activity of a cAMP receptor protein, has at least 80% sequence identity to the sequence of SEQ ID NO: 1, and has alanine at the position corresponding to position 35 of SEQ ID NO: 1.